Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Janosi, F. Petak, M. Beghetti, D. Morel, W. Habre (Szeged, Hungary; Geneva, Switzerland). Protection of vasoconstriction and lung function impairment by endothelin-receptor blockers and vasoactive intestinal peptide (VIP) in isolated perfused rat lungs. Eur Respir J 2007; 30: Suppl. 51, 485

Member's Comments

No comment yet.

Related content which might interest you: Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Vasoactive intestinal peptide (VIP) markedly attenuates pulmonary hypertension in fawn-hooded rats Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Discovery of competitive thromboxane receptor (TP) antagonism by diclofenac in guinea pig airway and vascular tissues Source: Annual Congress 2007 - Recent advances in airway smooth muscle biology Year: 2007 Endothelin-1-induced airway and parenchymal mechanical responses in guinea-pigs: the roles of ETA and ETB receptors Source: Eur Respir J 2001; 17: 975-981 Year: 2001 α1-adrenoceptor antagonism does not modify the pulmonary vasoconstrictor effect of dexfenfluramine in the rat Source: Eur Respir J 2001; 18: Suppl. 33, 491s Year: 2001 Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis Source: Eur Respir J 2004; 24: 958-963 Year: 2004 Endothelin-1 receptor antagonist prevents hyperoxia-induced parenchymal mechanical impairment in mice Source: Eur Respir J 2004; 24: Suppl. 48, 334s Year: 2004 The vasoactive effects of helospectins I and II in vivo are not mediated by VIP and PACAP1-38 receptors or vasodilator prostaglandins Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002 Acute increase in pulmonary blood flow elevates airway responsiveness in isolated perfused rat lungs Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research Year: 2008 Hypoxia causes permeability oedema in the constant-pressure perfused rat lung Source: Eur Respir J 2006; 27: 600-606 Year: 2006 Relaxin potentiates ß2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Inhalation of vasoactive intestinal peptide in pulmonary hypertension Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Inhaled budesonide causes rapid vasoconstriction in the isolated and perfused rat lung Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Effects of brain natriuretic peptide (BNP) on contractile response in human isolated bronchi Source: Annual Congress 2009 - Translational models of lung disease Year: 2009 Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Inhalation of vasoactive intestinal peptide in pulmonary hypertension Source: Eur Respir J 2008; 32: 1289-1294 Year: 2008 Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Anti-inflammatory activity of the bradykinin B1R antagonist in a model of LPS-induced lung inflammation in cynomolgus monkey Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016